| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/22/2008 | CA2288743C Pourable alginate compositions |
| 04/22/2008 | CA2174737C Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 04/17/2008 | WO2008046087A2 Spiro compounds and their uses as therapeutic agents |
| 04/17/2008 | WO2008044770A1 Agent for suppression of gastric emptying comprising 4-hydroxyisoleucine |
| 04/17/2008 | WO2008044767A1 Aromatic amine derivative and use thereof |
| 04/17/2008 | WO2008044700A1 GSK-3β INHIBITOR |
| 04/17/2008 | WO2008044660A1 Screening method for prokinetic agent |
| 04/17/2008 | WO2008044627A1 Prophylactic/therapeutic agent for liver disorder utilizing baculovirus |
| 04/17/2008 | WO2008044599A1 Polypeptide having activity of targeting intestine having inflammation, and use thereof |
| 04/17/2008 | WO2008043797A1 Use of modified cyclosporins |
| 04/17/2008 | WO2008043740A1 Use of lansoprazole for the treatment of frequent heartburn |
| 04/17/2008 | WO2008043424A2 Composition to treat or prevent gastrointestinal infection |
| 04/17/2008 | WO2008043263A1 Isoxazole derivatives and methods of treating diseases |
| 04/17/2008 | WO2008043175A1 SOLUBLE β-N-ACETYLGLUCOSAMINIDASE BASED ANTIBIOFILM COMPOSITIONS AND USES THEREOF |
| 04/17/2008 | WO2008025926A3 Salivary substitute |
| 04/17/2008 | WO2008019372A3 2-aminobenzoxazole carboxamides as 5ht3 modulators |
| 04/17/2008 | WO2008003748A3 Cd300lg polypeptides and their use in treating autoimmune diseases |
| 04/17/2008 | WO2006083710A3 Use of 5-ht4 agonist for treating delayed gastric emptying which may be induced by a proton pump inhibitor |
| 04/17/2008 | US20080091024 Processes for the production of substituted 2-(2-pyridylmethyl) sulfinyl-1H-benzimidazoles |
| 04/17/2008 | US20080090879 Method of treatment |
| 04/17/2008 | US20080090878 Pharmaceutical combinations and their use in treating gastrointestinal and abdominal viscera disorders |
| 04/17/2008 | US20080090877 Sulfone impurity can be removed using amine salts of 2-[(4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole when manufacturing the drug pariprazole |
| 04/17/2008 | US20080090858 Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands |
| 04/17/2008 | US20080090855 Substituted Cyclic Urea Derivatives and the Use Thereof as Vanilloid Receptor 1 Modulators |
| 04/17/2008 | US20080090846 Chemokine receptor binding heterocyclic compounds |
| 04/17/2008 | US20080090842 Novel pyridyl cyanoguanidine compounds |
| 04/17/2008 | US20080090830 thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failures and cancer |
| 04/17/2008 | US20080090819 DERIVATIVES OF [6,7-DIHYDRO-5H-IMIDAZO[1,2-a]IMIDAZOLE-3-SULFONYLAMINO]-PROPIONAMIDE |
| 04/17/2008 | US20080090811 Carbamate compounds as 5-HT4 receptor agonists |
| 04/17/2008 | US20080090803 Fatty alcohol drug conjugates |
| 04/17/2008 | US20080090797 tert-Butyl[3-(4-phenyloxazolidin-2-on-3-yl)-4-(2-styryl)azetidin-2-on-1-yl]acetate; known as synthetic intermediates for the preparation of beta -lactam antibiotics; diuretic |
| 04/17/2008 | US20080090795 Pharmaceutical Compositions Based on Nk2 Antagonists for Pediatric Use |
| 04/17/2008 | US20080090762 Epithelum-derived T-cell factor |
| 04/17/2008 | US20080090756 Somatostatin agonists |
| 04/17/2008 | US20080090749 Prophylactic/therapeutic agent for stress-induced bowel disease |
| 04/17/2008 | US20080089997 Partially Defatted Cocoa Solids Containing Conserved Amounts of Cocoa Polyphenols |
| 04/17/2008 | US20080089943 Use of adsorbent carbon microspheres to treat gastroesophogeal reflux disease |
| 04/17/2008 | US20080089883 Antisense oligonucleotides for prevention and/or treatment of infection, asthma, skin, inflammatory and/or autoimmune disorders |
| 04/17/2008 | US20080089882 Novel Polypeptide Useful for Cancer Diagnosis and Treatment |
| 04/17/2008 | US20080089879 Phytases and methods of making and using them |
| 04/17/2008 | US20080089877 Super Absorption Coenzyme Q10 |
| 04/17/2008 | CA2665769A1 Composition to treat and/or prevent gastrointestinal infection |
| 04/17/2008 | CA2665415A1 Use of modified cyclosporins |
| 04/16/2008 | EP1911837A2 FAD4, FAD5, FAD5-2, and FAD6, fatty acid desaturase family members and uses thereof |
| 04/16/2008 | EP1911763A2 Compositions for the treatment of gastrointestinal disorders |
| 04/16/2008 | EP1911740A1 Potassium channel modulators |
| 04/16/2008 | EP1911458A2 Cell-permeable peptide inhibitors of the JNK signal transduction pathway |
| 04/16/2008 | EP1911457A1 Composition to treat or prevent gastrointestinal infection |
| 04/16/2008 | EP1911449A1 Anti-tumor agent comprising 6'-amidino-2'-naphthyl4- guanidinobenzoate or salt thereof |
| 04/16/2008 | EP1910340A1 Indazolecarboxamide derivatives as 5ht4 receptor agonists |
| 04/16/2008 | EP1910313A1 6-thioamide substituted benzimidazoles |
| 04/16/2008 | EP1910296A2 4-aryloxy quinoline derivatives as 5-ht6 modulators |
| 04/16/2008 | EP1910293A1 Isotopically substituted proton pump inhibitors |
| 04/16/2008 | EP1909821A2 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |
| 04/16/2008 | EP1909802A2 Steroidal glycoside compounds as core 2 glcnac-t inhibitors |
| 04/16/2008 | EP1909600A1 Composition for moderating alcohol metabolism and for reducing the risk of alcohol induced diseases |
| 04/16/2008 | EP1545563B1 Composition and method for use in intestinal cleansing procedures |
| 04/16/2008 | EP1440059B1 3-azabicyclo(3.1.0)hexane derivatives as opioid receptor antagonists |
| 04/16/2008 | EP1423382B1 Pyrazole-derived kinase inhibitors and uses thereof |
| 04/16/2008 | EP1108039B1 Elongase genes and uses thereof |
| 04/16/2008 | CN101163701A Quinolinone compounds as 5-ht4 receptor agonists |
| 04/16/2008 | CN101163681A Phthalazinone derivative and pharmaceutical comprising the same |
| 04/16/2008 | CN101163669A Acetylene derivatives |
| 04/16/2008 | CN101163488A Composition anti-inflammatoire de l'intestin comprenant des maltodextrines branchees |
| 04/16/2008 | CN101161808A Dragon scorpion wine and method for making same |
| 04/16/2008 | CN101161668A Application of flavone c-glycosides in preparation of drugs curing and preventing hepatitis |
| 04/16/2008 | CN101161641A Tricyclic steroid hormone nuclear receptor modulators |
| 04/16/2008 | CN101161282A Blood circulation promoting nourishing kidney health preserving electric girdle |
| 04/16/2008 | CN101161264A A Chinese medicine preparation for easing-off head and neck neoplasm radiotheraphy secondary reaction |
| 04/16/2008 | CN101161256A Fossil oral liquid |
| 04/16/2008 | CN101161250A A novel enteron pharmaceutical preparation and its preparing method |
| 04/16/2008 | CN101161248A Novel anti-hepatitis B virus medicine and its preparing method |
| 04/16/2008 | CN101161232A Method of producing intravenous injection human hepatitis b immune globulin |
| 04/16/2008 | CN101161091A An antierythrite chewing gum |
| 04/16/2008 | CN100381462C Peptides and medicinal compositions containing the same |
| 04/16/2008 | CN100381454C Crystalline form of a ribofuranosyluronamide derivative: a human adenosine a2a receptor agonist |
| 04/16/2008 | CN100381440C Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 04/16/2008 | CN100381423C Novel piperidine derivatives as modulators of chemokine receptor CCR5 |
| 04/16/2008 | CN100381152C Medicinal granules of nourishing Yin and tonifying stomach, capsule and tablet preparing method |
| 04/16/2008 | CN100381142C A medicine for treating hepatitis |
| 04/16/2008 | CN100381136C Pharmaceutical composition for treating constipation, its formulation and preparation process thereof |
| 04/16/2008 | CN100381128C Inclusion compound of ants supercritical extracts and preparation process thereof |
| 04/16/2008 | CN100381127C Deer-medulla liquid and use thereof |
| 04/16/2008 | CN100381126C Treating agent of plant poly pentene alcohol gor liver damage |
| 04/16/2008 | CN100381120C Fibrauretine powder for injection and its production process |
| 04/16/2008 | CN100381061C Method for preparing digestion-promoting spleen-invigorating yoghourt with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen |
| 04/16/2008 | CN100381060C Method for preparing liver-benefiting, face-beautifying yoghout with micron pine pollen, pearl powder for women |
| 04/15/2008 | US7358354 Administering genetically engineered vectors to modulate lymphocytes; transfecting macrophages; used for prophylaxis or treatments for cancers or immune-related disorders |
| 04/15/2008 | US7358341 Secreted protein for use in diagnosis, prevention and treatment of thyroid gland disorders |
| 04/15/2008 | US7358333 Polypeptides of the IFNα-5 gene |
| 04/15/2008 | US7358272 Reduction of levels of tumor necrosis factor-alpha and/or inhibition of phosphodiesterase 4; treating cancer, especially various types of leukemia |
| 04/15/2008 | US7358265 Oxa-and thiadiazoles and their use as metalloproteinase inhibitors |
| 04/15/2008 | US7358261 Heteroaryl alkylamide derivatives useful as bradykinin receptor modulators |
| 04/15/2008 | US7358260 Quinuclidine derivatives and medicinal compositions containing the same |
| 04/15/2008 | US7358252 Psychological disorders; central nervous system disorders; antidepressants; anxiolytic agents; stress reliever |
| 04/15/2008 | US7358245 Administering a therapeutically effective amount of a compound which is a cannabinoid receptor agonist, a pharmaceutically acceptable salt of the compound, an isomer of the compound, or a pharmaceutically acceptable salt of the isomer |
| 04/15/2008 | US7358243 1-[9-(3-Phenyl-allyl)-3,9 diaza-bicyclo[4.2.1]non-3-yl]-propan-1-one; analgesic; great selectivity to mu receptor; analgesic; pain relief, drug dependence, alcoholism; side effect reduction |
| 04/15/2008 | US7358239 Treating impaired fundic relaxation; [1(R),[A-(3 alpha ,4 alpha )]]-1-[1-[(3,4-dihydro-2H-1-benzopyran-2-yl)methyl]-3-methoxy-4-piperidinyl]-2(1H)-pyrimidinone |
| 04/15/2008 | US7358074 Human phosphatase RET31, and variants thereof |
| 04/15/2008 | US7358058 Method and agents for the diagnosis and therapy of chronic inflammatory intestinal disease |